Collegium Pharmaceutical (COLL) Non-cash Items (2014 - 2025)
Collegium Pharmaceutical (COLL) recorded quarterly Non-cash Items of $493716.0 in Q3 2025, down 99.36% quarter-over-quarter from $76.7 million in Q2 2025, and down 27.83% on a YoY basis from $684083.0 in Q3 2024.
Collegium Pharmaceutical (COLL) Non-cash Items (2014 - 2025) Analysis & Trends
Collegium Pharmaceutical's Non-cash Items history runs 12 years deep, the most recent figure standing at $493716.0 for Q3 2025.
- In Q3 2025, Non-cash Items fell 27.83% year-over-year to $493716.0; the TTM figure through Sep 2025 stood at $493716.0 (down 27.83% YoY), while the FY2024 annual figure was $673062.0, down 41.89% from the prior year.
- Non-cash Items was $493716.0 for Q3 2025 at Collegium Pharmaceutical, down from $76.7 million in the prior quarter.
- In the past five years, Non-cash Items ranged from a high of $82.4 million in Q1 2025 to a low of $493716.0 in Q3 2025.
- Historically, Non-cash Items has averaged $30.8 million across 5 years, with a median of $13.3 million in 2023.
- The sharpest annual moves came in 2024 and 2025: Non-cash Items sank 98.63% in 2024, then surged 8352.82% in 2025.
- A 5-year view of Non-cash Items shows it stood at $6.1 million in 2021, then surged by 31.02% to $8.0 million in 2022, then jumped by 67.19% to $13.3 million in 2023, then tumbled by 50.11% to $6.6 million in 2024, then plunged by 92.56% to $493716.0 in 2025.
- The last three Non-cash Items figures came in at $493716.0 (Q3 2025), $76.7 million (Q2 2025), and $82.4 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Collegium Pharmaceutical | 1.10 Bn | 813.71 Mn | 117.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 493,716.00 |
| Sep 30, 2025 | 493,716.00 |
| Jun 30, 2025 | 76.71 Mn |
| Jun 30, 2025 | 76.71 Mn |
| Mar 31, 2025 | 82.41 Mn |
| Mar 31, 2025 | 82.41 Mn |
| Dec 31, 2024 | 6.63 Mn |
| Dec 31, 2024 | 6.63 Mn |
| Sep 30, 2024 | 684,083.00 |
| Sep 30, 2024 | 684,083.00 |
| Jun 30, 2024 | 52.29 Mn |
| Jun 30, 2024 | 52.29 Mn |
| Mar 31, 2024 | 974,941.00 |
| Mar 31, 2024 | 974,941.00 |
| Dec 31, 2023 | 13.30 Mn |
| Dec 31, 2023 | 13.30 Mn |
| Sep 30, 2023 | 50.04 Mn |
| Sep 30, 2023 | 50.04 Mn |
| Jun 30, 2023 | 57.29 Mn |
| Jun 30, 2023 | 57.29 Mn |